SIMPLE YET BRILLIANT

Developing an oral drug product is rarely straightforward. Many active pharmaceutical ingredients (APIs) exhibit poor aqueous solubility, limited permeability, or stability issues that can affect bioavailability and ultimately clinical performance. Addressing these challenges early in development is critical for reducing risk and avoiding delays later on. For companies without dedicated formulation teams or specialized equipment, working with an oral formulation CRO can provi

Poorly soluble drugs pose a major challenge in pharmaceutical development. Many active pharmaceutical ingredients (APIs) struggle to dissolve effectively, limiting their absorption and therapeutic impact. A promising solution lies in a natural, renewable material: porous cellulose derived from green macroalgae. This approach offers a sustainable, efficient way to improve drug solubility and delivery. Why Poor Solubility Matters in Drug Delivery Many new drugs have low water s